Structures by: Salmon D. J.
Total: 30
(4-bromo-PhC(CN)(=NOH)), 3-bromo-5-methoxypyridine
(C8H5BrN2O)(C6H6BrNO)
CrystEngComm (2009) 11, 3 439-443
a=6.9907(6)Å b=8.0552(7)Å c=15.3027(13)Å
α=79.305(5)° β=89.038(5)° γ=64.660(5)°
(4-bromo-PhC(CN)(=NOH)), 1-(4-bromobenzyl)-2- methylbenzimidazole
(C8H5BrN2O)(C15H13BrN2)
CrystEngComm (2009) 11, 3 439-443
a=4.9374(6)Å b=22.597(3)Å c=19.233(2)Å
α=90.00° β=96.869(2)° γ=90.00°
4-bromo-PhC(CN)(N=OH), (3-((5,6-dimethylbenzimidazol-1- yl)methyl)PhCN
(C8H5N2OBr)(C17H15N3)
CrystEngComm (2009) 11, 3 439-443
a=6.039(3)Å b=13.982(6)Å c=14.166(6)Å
α=70.067(19)° β=83.78(3)° γ=82.22(3)°
(4-bromo-PhC(CN)(=NOH)), 1-(4-bromobenzyl)benzimidazole
(C8H5BrN2O)(C14H11BrN2)
CrystEngComm (2009) 11, 3 439-443
a=5.3033(6)Å b=13.2294(15)Å c=15.0601(17)Å
α=102.536(2)° β=99.505(2)° γ=94.752(2)°
(2-fluoro-PhC(CN)(=NOH))2, 1,2-di(4-pyridyl)ethene
(C8H5N2OF)2(C12H10N2)
CrystEngComm (2009) 11, 3 439-443
a=3.8189(6)Å b=11.2941(18)Å c=14.107(2)Å
α=98.884(10)° β=93.147(11)° γ=94.624(10)°
481 1,4-di((1-benzimidazolyl)methyl)benzene, (3-chloro- PhC(CN)(=NOH))2
(C22H18N4)(C8H5N2OCl)2
CrystEngComm (2009) 11, 3 439-443
a=13.6335(10)Å b=4.4402(3)Å c=27.297(2)Å
α=90.00° β=94.084(3)° γ=90.00°
MS 512 1-(4-pyridylmethyl)-5,6-Me2benzimidazole, 4-F- PhC(CN)(NOH)
(C15H15N3)(C8H5N2OF)
CrystEngComm (2009) 11, 3 439-443
a=16.1659(12)Å b=6.4146(5)Å c=21.0074(16)Å
α=90.00° β=105.945(5)° γ=90.00°
(4-bromo-PhC(CN)(=NOH)), 3-bromo-5-methoxypyridine
(C8H5BrN2O)(C6H6BrNO)
CrystEngComm (2009) 11, 3 439-443
a=6.9907(6)Å b=8.0552(7)Å c=15.3027(13)Å
α=79.305(5)° β=89.038(5)° γ=64.660(5)°
(4-bromo-PhC(CN)(=NOH)), 1-(4-bromobenzyl)-2- methylbenzimidazole
(C8H5BrN2O)(C15H13BrN2)
CrystEngComm (2009) 11, 3 439-443
a=4.9374(6)Å b=22.597(3)Å c=19.233(2)Å
α=90.00° β=96.869(2)° γ=90.00°
(4-bromo-PhC(CN)(=NOH)), 1-(4-bromobenzyl)benzimidazole
(C8H5BrN2O)(C14H11BrN2)
CrystEngComm (2009) 11, 3 439-443
a=5.3033(6)Å b=13.2294(15)Å c=15.0601(17)Å
α=102.536(2)° β=99.505(2)° γ=94.752(2)°
(2-fluoro-PhC(CN)(=NOH))2, 1,2-di(4-pyridyl)ethene
(C8H5N2OF)2(C12H10N2)
CrystEngComm (2009) 11, 3 439-443
a=3.8189(6)Å b=11.2941(18)Å c=14.107(2)Å
α=98.884(10)° β=93.147(11)° γ=94.624(10)°
4-bromo-PhC(CN)(N=OH), (3-((5,6-dimethylbenzimidazol-1- yl)methyl)PhCN
(C8H5N2OBr)(C17H15N3)
CrystEngComm (2009) 11, 3 439-443
a=6.039(3)Å b=13.982(6)Å c=14.166(6)Å
α=70.067(19)° β=83.78(3)° γ=82.22(3)°
481 1,4-di((1-benzimidazolyl)methyl)benzene, (3-chloro- PhC(CN)(=NOH))2
(C22H18N4)(C8H5N2OCl)2
CrystEngComm (2009) 11, 3 439-443
a=13.6335(10)Å b=4.4402(3)Å c=27.297(2)Å
α=90.00° β=94.084(3)° γ=90.00°
MS 512 1-(4-pyridylmethyl)-5,6-Me2benzimidazole, 4-F- PhC(CN)(NOH)
(C15H15N3)(C8H5N2OF)
CrystEngComm (2009) 11, 3 439-443
a=16.1659(12)Å b=6.4146(5)Å c=21.0074(16)Å
α=90.00° β=105.945(5)° γ=90.00°
(4-bromo-phenylacetonitrile oxime)2, 1,4-di[(1-benzimidazolyl)methyl]benzene
(C8H5BrN2O)2(C22H18N4)
Crystal Growth & Design (2006) 6, 4 1033
a=11.436(4)Å b=5.640(2)Å c=26.449(9)Å
α=90.00° β=99.252(5)° γ=90.00°
(4-bromo-phenylacetonitrile oxime)2, 1,4-di[(1-imidazolyl)methyl]benzene
(C8H5BrN2O)2(C14H14N4)
Crystal Growth & Design (2006) 6, 4 1033
a=12.9436(5)Å b=5.1863(2)Å c=21.6419(9)Å
α=90.00° β=93.4500(10)° γ=90.00°
(4-bromo-PhC(CN)(=NOH))2, 1,4-di[(2-methyl-1-benzimidazolyl)methyl]benzene
(C8H5BrN2O)2(C24H22N4)
Crystal Growth & Design (2006) 6, 4 1033
a=7.4360(9)Å b=19.613(2)Å c=12.5107(15)Å
α=90.00° β=107.063(2)° γ=90.00°
(4-bromo-PhC(CN)(=NOH))2, 1,4-di[(2-methyl-1-imidazolyl)methyl]benzene
(C8H5BrN2O)2(C16H18N4)
Crystal Growth & Design (2006) 6, 4 1033
a=7.0034(8)Å b=10.6013(12)Å c=11.1605(12)Å
α=77.000(2)° β=75.995(2)° γ=84.920(2)°
(3-chloro-phenylacetonitrile oxime)2, 1,4-di[(1-imidazolyl)methyl]benzene
(C8H5ClN2O)2(C14H14N4)
Crystal Growth & Design (2006) 6, 4 1033
a=5.9000(10)Å b=7.2231(12)Å c=17.088(3)Å
α=86.114(3)° β=89.633(4)° γ=73.472(3)°
1,4-[bis(2-methylbenzimidazol-1-yl)methyl]benzene, (4-bromobenzacetoxime)2
(C24H22N4)(C8H8NOBr)2
Crystal Growth & Design (2006) 6, 4 1033
a=10.9286(11)Å b=14.1612(15)Å c=11.3704(12)Å
α=90.00° β=92.619(2)° γ=90.00°
11228a
C34H43CuN3O3,2(CH2Cl2)
Inorganic chemistry (2014) 53, 11 5788-5796
a=10.3780(9)Å b=13.5976(12)Å c=14.1980(13)Å
α=109.0600(10)° β=90.7160(10)° γ=98.7430(10)°
12022s
C30H35CuN3O3,CH2Cl2
Inorganic chemistry (2014) 53, 11 5788-5796
a=16.9991(8)Å b=13.5041(7)Å c=16.7200(8)Å
α=90.00° β=109.2390(10)° γ=90.00°
12245b
C34H44CuN4O,2(F6Sb),CH2Cl2
Inorganic chemistry (2014) 53, 11 5788-5796
a=12.9023(6)Å b=19.3103(9)Å c=17.8355(9)Å
α=90.00° β=93.7960(10)° γ=90.00°
12171e
C32H43CuN3O3,2(F6Sb),3(C4H8O),CH2Cl2
Inorganic chemistry (2014) 53, 11 5788-5796
a=13.9719(7)Å b=14.6765(7)Å c=16.1109(8)Å
α=97.7770(10)° β=103.9150(10)° γ=114.5700(10)°
12217a
C28H33Cl2CoN3O,C4H10O,C2H3N,H2O
Inorganic chemistry (2014) 53, 11 5788-5796
a=14.6340(10)Å b=15.6687(11)Å c=16.1572(11)Å
α=90.00° β=103.6310(10)° γ=90.00°
12152
C28H33Cl2N3OZn,4(C2H3N)
Inorganic chemistry (2014) 53, 11 5788-5796
a=25.876(5)Å b=8.9106(16)Å c=35.414(6)Å
α=90.00° β=106.930(2)° γ=90.00°
12134
C24H24ClCuN3O
Inorganic chemistry (2014) 53, 11 5788-5796
a=8.8885(14)Å b=13.849(2)Å c=17.692(3)Å
α=90.00° β=90.00° γ=90.00°
11238a
C28H35N3O
Inorganic chemistry (2014) 53, 11 5788-5796
a=11.8952(9)Å b=12.1727(9)Å c=17.5867(13)Å
α=90.00° β=90.00° γ=90.00°
IPr2LCuCl
C32H40ClCuN3O
Inorganic chemistry (2014) 53, 11 5788-5796
a=29.888(3)Å b=13.4602(15)Å c=16.7818(19)Å
α=90.00° β=90.00° γ=90.00°
11236
C28H32ClCuN3O,CH2Cl2
Inorganic chemistry (2014) 53, 11 5788-5796
a=9.6620(12)Å b=12.0158(16)Å c=14.1155(18)Å
α=89.148(2)° β=87.476(2)° γ=67.6840(10)°